Published guidance, NICE advice and quality standards | Guidance

Showing 191 to 200 of 331

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Alectinib for untreated ALK-positive advanced non-small-cell lung cancer	TA536	8 August 2018	8 August 2018
Pembrolizumab for untreated PD-L1-positive metastatic non-small-cell lung cancer	TA531	18 July 2018	18 July 2018
Nivolumab for treating locally advanced unresectable or metastatic urothelial cancer after platinum-containing chemotherapy	TA530	4 July 2018	4 July 2018
Cancer of the upper aerodigestive tract: assessment and management in people aged 16 or over	NG36	10 February 2016	6 June 2018
Atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer after chemotherapy	TA520	16 May 2018	16 May 2018
ColonFlag for identifying people at risk of colorectal cancer	MIB142	12 April 2018	12 April 2018
Eribulin for treating locally advanced or metastatic breast cancer after 1 chemotherapy regimen	TA515	28 March 2018	28 March 2018
Cabozantinib for treating medullary thyroid cancer	TA516	28 March 2018	28 March 2018
Pertuzumab with trastuzumab and docetaxel for treating HER2-positive breast cancer	TA509	7 March 2018	7 March 2018
Pancreatic cancer in adults: diagnosis and management	NG85	7 February 2018	7 February 2018